![7-Oxabicyclo[2.2.1]heptane (CAS 279-49-2) - chemical structure image](https://media.scbt.com/product/7-oxabicyclo2-2-1heptane-279-49-2-structure_11_16_b_111627.jpg)
![7-Oxabicyclo[2.2.1]heptane (CAS 279-49-2) - chemical structure image](https://media.scbt.com/product/7-oxabicyclo2-2-1heptane-279-49-2-structure_11_16_t_111627.jpg "Molecular structure of 7-Oxabicyclo[2.2.1]heptane, CAS Number: 279-49-2")
Molecular structure of 7-Oxabicyclo[2.2.1]heptane, CAS Number: 279-49-2
7-Oxabicyclo[2.2.1]heptane (CAS 279-49-2)
Alternate Names:
1,4-Epoxycyclohexane
CAS Number:
279-49-2
Molecular Weight:
98.14
Molecular Formula:
C6H10O
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
7-Oxabicyclo[2.2.1]heptane functions as a bridging agent in organic synthesis. It acts as a versatile building block in the construction of complex molecular structures, facilitating the formation of various cyclic compounds. Its mechanism of action involves participating in Diels-Alder reactions and other cycloaddition processes, enabling the creation of fused ring systems and diverse chemical architectures. Through its reactivity and ability to undergo ring-opening and ring-closing reactions, 7-Oxabicyclo[2.2.1]heptane contributes to the development of novel compounds with potential applications in materials science and chemical biology.
7-Oxabicyclo[2.2.1]heptane (CAS 279-49-2) References
- Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system. | Limpongsa, E. and Umprayn, K. 2008. AAPS PharmSciTech. 9: 464-70. PMID: 18431661
- Sustained release of diltiazem hydrochloride from chitosan micro-capsules. | Farhana, SA., et al. 2009. Curr Drug Deliv. 6: 238-48. PMID: 19604137
- Facial hyperpigmentation caused by diltiazem hydrochloride. | Desai, N., et al. 2010. Cutis. 86: 82-4. PMID: 20919601
- Design and development of diltiazem hydrochloride transmucosal drug delivery system. | Penjuri, SC., et al. 2013. Ceska Slov Farm. 62: 19-27. PMID: 23578264
- Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags. | Kaushal, G., et al. 2013. Am J Health Syst Pharm. 70: 894-9. PMID: 23640351
- In vitro and ex vivo studies on diltiazem hydrochloride-loaded microsponges in rectal gels for chronic anal fissures treatment. | Ivanova, NA., et al. 2019. Int J Pharm. 557: 53-65. PMID: 30580086
- Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use. | Teimouri, A., et al. 2020. Int J Pharm Compd. 24: 482-490. PMID: 33217738
- Formulation and characterization of orodispersible film containing diltiazem hydrochloride with taste masked effects. | Latif, S., et al. 2022. Pak J Pharm Sci. 35: 1007-1014. PMID: 36008896
- Calcium-channel blocking agents. | Leonard, RG. and Talbert, RL. 1982. Clin Pharm. 1: 17-33. PMID: 6764159
- Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia. | Rozanski, JJ., et al. 1982. Am J Cardiol. 49: 621-8. PMID: 7058770
- Diltiazem: ten years of clinical experience in the treatment of hypertension. | Weir, MR. 1995. J Clin Pharmacol. 35: 220-32. PMID: 7608309
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
7-Oxabicyclo[2.2.1]heptane, 5 g | sc-233696 | 5 g | $126.00 |